RxDoctor Payments Data

Richard Brown, DO

Obstetrics & Gynecology · Gulf Shores, ALNPI 1235428772

Payments from drug & device makers

What this record shows

This record is dominated by education: $313,083 of the $428,757 with a category attached, or 73.0%. Intuitive Surgical accounts for 99.8% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $134,362, more than ten times the $253 reported in 2019. Among obstetrics & gynecology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$428,757in general payments, 2019–2025

Across 538 payments — averaging $796.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$428K
  • Orexo US, Inc.$152
  • AbbVie$135
  • Hologic Sales And Service, LLC$132
  • BD$74
  • Indivior Inc.$52
  • plus $274 from 14 others

What the payments were for

  • Speaking & faculty fees$12,0003%
  • Travel & lodging$79,29618%
  • Food & beverage$24,3786%
  • Education$313,08373%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$428,757 in reported general payments places this provider in the 95th percentile of 537 obstetrics & gynecology providers in Alabama.

See all obstetrics & gynecology providers in Alabama

Medicare billing

Part B allowed, 2024
$18,786
Medicare patients
40
Services billed
143

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl212$46,367
ZubsolvBuprenorphine Hcl/Naloxone Hcl12$14,910
SuboxoneBuprenorphine Hcl/Naloxone Hcl19$12,871
Estradiol54$2,678
ProgesteroneProgesterone, Micronized52$1,762
Testosterone Cypionate81$1,170
Ondansetron OdtOndansetron53$595
Scopolamine28$324
Liothyronine Sodium18$264
Ibuprofen15$247
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen31$216
Zolpidem Tartrate22$197
Fluconazole11$144
Lisinopril13$45
Alprazolam15$45

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Orexo US, Inc.Zubsolv$152$14,91012 claims
Indivior Inc.Suboxone$52$12,87119 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 537 obstetrics & gynecology providers in Alabama.

Other obstetrics & gynecology in Gulf Shores

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →